Secondary preventive drug therapy following acute myocardial infarction (AMI) is recommended to reduce the risk of new cardiovascular events. The aim of this nationwide cohort study was to examine the initiation and long-term use of secondary preventive drugs after AMI.
The prescription of drugs in 42,707 patients
Cites: Eur Heart J. 2006 May;27(10):1153-816399775
Cites: Scand Cardiovasc J. 2016 Apr;50(2):99-10726564402